Table 2 Correlations between RBC concentrations of total MTXPGs and variable clinical parameters in patients with RA receiving MTX therapy.
Total MTXPGs | |||||
---|---|---|---|---|---|
Univariate model | Multivariate model | ||||
β | p value | R2 | β | p value | |
Sex | 0.019 | 0.761 | 0.019 | −0.014 | 0.822 |
Duration | 0.012 | 0.842 | 0.012 | 0.127 | 0.095 |
Dose of methotrexate | 0.399 | 0.000 | 0.156 | 0.421 | 0.000 |
Age | 0.102 | 0.099 | 0.007 | 0.162 | 0.081 |
Stage | 0.102 | 0.112 | 0.112 | −0.019 | 0.802 |
DAS28-ESR | 0.091 | 0.147 | 0.004 | 0.049 | 0.432 |
R2 | 0.180 |